首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   81135篇
  免费   9077篇
  国内免费   2731篇
电工技术   4618篇
技术理论   16篇
综合类   4579篇
化学工业   14378篇
金属工艺   2764篇
机械仪表   3623篇
建筑科学   19430篇
矿业工程   2072篇
能源动力   1621篇
轻工业   7077篇
水利工程   2229篇
石油天然气   2199篇
武器工业   468篇
无线电   5514篇
一般工业技术   7201篇
冶金工业   3612篇
原子能技术   664篇
自动化技术   10878篇
  2024年   271篇
  2023年   1313篇
  2022年   3404篇
  2021年   4557篇
  2020年   2624篇
  2019年   2389篇
  2018年   2517篇
  2017年   3265篇
  2016年   4563篇
  2015年   5125篇
  2014年   6480篇
  2013年   6549篇
  2012年   4814篇
  2011年   4484篇
  2010年   3713篇
  2009年   3974篇
  2008年   3618篇
  2007年   4932篇
  2006年   4905篇
  2005年   4111篇
  2004年   2811篇
  2003年   2571篇
  2002年   2051篇
  2001年   1512篇
  2000年   1305篇
  1999年   866篇
  1998年   560篇
  1997年   475篇
  1996年   404篇
  1995年   339篇
  1994年   341篇
  1993年   227篇
  1992年   199篇
  1991年   177篇
  1990年   181篇
  1989年   143篇
  1988年   96篇
  1987年   98篇
  1986年   77篇
  1985年   110篇
  1984年   108篇
  1983年   78篇
  1982年   52篇
  1981年   44篇
  1980年   54篇
  1966年   29篇
  1964年   38篇
  1962年   69篇
  1959年   31篇
  1954年   27篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Hepatic fibrosis occurs when liver tissue becomes scarred from repetitive liver injury and inflammatory responses; it can progress to cirrhosis and eventually to hepatocellular carcinoma. Previously, we reported that neoagarooligosaccharides (NAOs), produced by the hydrolysis of agar by β-agarases, have hepatoprotective effects against acetaminophen overdose-induced acute liver injury. However, the effect of NAOs on chronic liver injury, including hepatic fibrosis, has not yet been elucidated. Therefore, we examined whether NAOs protect against fibrogenesis in vitro and in vivo. NAOs ameliorated PAI-1, α-SMA, CTGF and fibronectin protein expression and decreased mRNA levels of fibrogenic genes in TGF-β-treated LX-2 cells. Furthermore, downstream of TGF-β, the Smad signaling pathway was inhibited by NAOs in LX-2 cells. Treatment with NAOs diminished the severity of hepatic injury, as evidenced by reduction in serum alanine aminotransferase and aspartate aminotransferase levels, in carbon tetrachloride (CCl4)-induced liver fibrosis mouse models. Moreover, NAOs markedly blocked histopathological changes and collagen accumulation, as shown by H&E and Sirius red staining, respectively. Finally, NAOs antagonized the CCl4-induced upregulation of the protein and mRNA levels of fibrogenic genes in the liver. In conclusion, our findings suggest that NAOs may be a promising candidate for the prevention and treatment of chronic liver injury via inhibition of the TGF-β/Smad signaling pathway.  相似文献   
2.
纳米药物非临床药代动力学的研究策略及关注要点   总被引:1,自引:0,他引:1  
随着纳米技术的迅速发展,纳米药物的研发已成为目前药物创新的发展方向之一。纳米药物具有基于纳米结构的尺度效应,其药代动力学特征与普通药物相比存在明显差异,其药代动力学研究与普通药物相比也有其特殊性。本文着重探讨纳米药物的非临床药代动力学的研究策略及关注要点,包括受试物、体内/外试验、生物样本分析、数据评价分析等,期望为研发者提供参考。  相似文献   
3.
4.
熊小明  赵静 《电信科学》2022,38(11):163-168
基于电信运营商数字化转型,系统性地提出了数据驱动的云网发展规划体系,以及六大关键数字化能力构建,设计和实现了一种云网规划数字化平台,该平台可用于实现目标网络精细规划、边缘计算精准预测等场景,并探讨了数字孪生在规划领域的应用前景,对运营商推进云网融合战略、推进高质量发展具有指导和参考意义。  相似文献   
5.
6.
Piperine is an alkaloid that has extensive pharmacological activity and impacts other active substances bioavailability due to inhibition of CYP450 enzymes, stimulation of amino acid transporters and P-glycoprotein inhibition. Low solubility and the associated low bioavailability of piperine limit its potential. The combination of piperine with 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) causes a significant increase in its solubility and, consequently, an increase in permeability through gastrointestinal tract membranes and the blood–brain barrier. X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR) were used to characterize interactions between piperine and HP-β-CD. The observed physicochemical changes should be combined with the process of piperine and CD system formation. Importantly, with an increase in solubility and permeability of piperine as a result of interaction with CD, it was proven to maintain its biological activity concerning the antioxidant potential (2,2-diphenyl-1-picryl-hydrazyl-hydrate assay), inhibition of enzymes essential for the inflammatory process and for neurodegenerative changes (hyaluronidase, acetylcholinesterase, butyrylcholinesterase).  相似文献   
7.
8.
为研究金针菇多糖(polysaccharide from Flammulina velutipes,FVP)对微冻大黄鱼及鱼片在贮藏期间肌原纤维蛋白性质的变化及水分分布的影响,实验分别选用0.03、0.06、0.09 g/L FVP浸渍处理大黄鱼和鱼片,以无菌水处理为对照组,分析微冻贮藏期间样品的感官指标得分、总挥发性盐基氮含量、总巯基含量、Ca2+-ATPase活性、蛋白流变学性质以及水分迁移变化规律。结果表明:FVP可有效抑制整鱼总挥发性盐基氮含量上升和感官得分的下降;减缓整鱼及鱼片在微冻过程中总巯基含量、Ca2+-ATPase活性下降和水分流失;此外FVP还能够延缓大黄鱼因腐败而出现的蛋白凝胶能力减弱。在本实验选取的多糖浓度范围内,0.09 g/L FVP处理组保鲜效果较强。该研究结果可为FVP用于水产品贮运保鲜提供理论参考。  相似文献   
9.
10.
Cell surface and secreted proteins provide essential functions for multicellular life. They enter the endoplasmic reticulum (ER) lumen co-translationally, where they mature and fold into their complex three-dimensional structures. The ER is populated with a host of molecular chaperones, associated co-factors, and enzymes that assist and stabilize folded states. Together, they ensure that nascent proteins mature properly or, if this process fails, target them for degradation. BiP, the ER HSP70 chaperone, interacts with unfolded client proteins in a nucleotide-dependent manner, which is tightly regulated by eight DnaJ-type proteins and two nucleotide exchange factors (NEFs), SIL1 and GRP170. Loss of SIL1′s function is the leading cause of Marinesco-Sjögren syndrome (MSS), an autosomal recessive, multisystem disorder. The development of animal models has provided insights into SIL1′s functions and MSS-associated pathologies. This review provides an in-depth update on the current understanding of the molecular mechanisms underlying SIL1′s NEF activity and its role in maintaining ER homeostasis and normal physiology. A precise understanding of the underlying molecular mechanisms associated with the loss of SIL1 may allow for the development of new pharmacological approaches to treat MSS.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号